echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > New use of old medicine!

    New use of old medicine!

    • Last Update: 2021-09-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Rubik's Cube Info

    Author: Sunshine

    On September 7, Servier and Neurochlore announced that in two phase III clinical studies evaluating bumetanide and placebo in the treatment of autism spectrum disorder (ASD) in children and adolescents, no difference in efficacy was observed


    Autism, also known as autism, is a disorder of mental development that occurs in infants and young children.


    Bumetanide is a powerful diuretic that works by inhibiting the sodium-potassium-chloride cotransporter (NKCC1)


    These two randomized, double-blind, placebo-controlled Phase III clinical trials were launched 4 years ago and were carried out in 14 countries (including 11 European countries)


    Previously, the Ib trial of bumetanide in the treatment of autism was carried out by Neurochlore, which included 90 subjects in 6 centers in France


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.